單位人員計畫
(單位計畫)


第 1 到 108 筆結果，共 108 筆。

啟始時間標題P-Investigator經費來源
2023To Explore Acquired Resistance to Anti-Egfr Agents in Colorectal Cancer for the Development of Potential Treatment Strategies—Focusing on Met, Her2, Kras G12c and Pik3ca PathwayKUN-HUEI YEHNational Science and Technology Council
2023Establishing Immuno-Competent Mouse Esophageal Squamous Cell Carcinoma Models for Developing Strategies to Improve the Efficacy of Anti-Pd-1/Pd-L1 Immune Checkpoint Blockade( II )CHIH-HUNG HSUNational Science and Technology Council
2023國立臺灣大學高等教育深耕計畫－特色領域研究中心 【子計畫三_癌症】CHIH-HSIN YANGMinistry of Education
2023跨機構合作的癌症轉譯研究計畫-大腸直腸癌之跨機構整合研究：由癌症發生預防學至腫瘤預後與治療學的全方位策略(第1年)KUN-HUEI YEHMinistry of Health and Welfare
2023大腸直腸癌之跨機構整合研究：由癌症發生預防學至腫瘤預後與治療學的全方位策略(第2年)KUN-HUEI YEHMinistry of Health and Welfare
2022Establishing Immuno-Competent Mouse Esophageal Squamous Cell Carcinoma Models for Developing Strategies to Improve the Efficacy of Anti-Pd-1/Pd-L1 Immune Checkpoint Blockade( I )CHIH-HUNG HSUNational Science and Technology Council
2022Intrinsic Activities of Program Death Ligand 1 Promote Progression and Metastasis in Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2021Targeting Myeloid-derived Suppressor Cells (MDSCs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (PD-1)-blockade Immunotherapy against CancersCHIH-HUNG HSUNational Science and Technology Council
2021Intrinsic Activities of Program Death Ligand 1 Promote Progression and Metastasis in Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2021第3期癌症研究中心計畫－臺大醫院建置癌症卓越研究體系第三期(107-110年)計畫(第4年)KUN-HUEI YEHMinistry of Health and Welfare
2021高等教育深耕計畫－特色領域研究中心【子計畫三_癌症】CHIH-HSIN YANGHigher Education Sprout Project
2020Targeting Myeloid-derived Suppressor Cells (MDSCs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (PD-1)-blockade Immunotherapy against CancersCHIH-HUNG HSUNational Science and Technology Council
2020Dissecting Factors Contributing to Tumor Evolution: Emergence of T790m or Non-T790m as Resistant Mechanism in Egfr Mutant Lung CancerCHIH-HSIN YANGNational Science and Technology Council
2020Taiwan Clinical Trial Consortium for Lung Cancer ⅣCHIH-HSIN YANGNational Science and Technology Council
2019第3期癌症研究中心計畫－臺大醫院建置癌症卓越研究體系第三期(107-110年)計畫(第3年)KUN-HUEI YEHMinistry of Health and Welfare
2019Targeting Myeloid-derived Suppressor Cells (MDSCs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (PD-1)-blockade Immunotherapy against CancersCHIH-HUNG HSUNational Science and Technology Council
2019Dissecting Factors Contributing to Tumor Evolution: Emergence of T790m or Non-T790m as Resistant Mechanism in Egfr Mutant Lung CancerCHIH-HSIN YANGNational Science and Technology Council
2019Targeting Myeloid-Derived Suppressor Cells (Mdscs) to Improve the Therapeutic Efficacy of Programmed Cell Death Protein-1 (Pd-1)- Blockade Immunotherapy against CancersCHIH-HUNG HSUNational Science and Technology Council
2019The Correlative Study between Immune Surface Markers with Dynamic Changes and Efficacy of Anti-Cancer Agents for Patients of Metastatic Colorectal Cancers (Crcs) ─ Exploration on Potential Novel Targets of Immunotherapy in CrcsKUN-HUEI YEHNational Science and Technology Council
2019臺灣肺癌臨床試驗合作聯盟 IIICHIH-HSIN YANGNational Science and Technology Council
2019高等教育深耕計畫－特色領域研究中心－【子計畫三_癌症】CHIH-HSIN YANGHigher Education Sprout Project
2019Center of Excellence for Cancer Research (2018 to 2021), National Taiwan University HospitalCHIH-HSIN YANGMinistry of Health and Welfare
2018Taiwan Clinical Trial Consortium for Lung CancerCHIH-HSIN YANGNational Science and Technology Council
2018Dissecting Factors Contributing to Tumor Evolution: Emergence of T790m or Non-T790m as Resistant Mechanism in Egfr Mutant Lung CancerCHIH-HSIN YANGNational Science and Technology Council
2018Deciphering Tumor Immune-Microenvironment in Predciting the Efficacy of Program Cell Death 1 (Pd-1) Checkpoint Bloackade Therapy in Esophageal Squamous Cell CarcinomaCHIH-HUNG HSUNational Science and Technology Council
2018The Correlative Study between Immune Surface Markers with Dynamic Changes and Efficacy of Anti-Cancer Agents for Patients of Metastatic Colorectal Cancers (Crcs) ─ Exploration on Potential Novel Targets of Immunotherapy in CrcsKUN-HUEI YEHNational Science and Technology Council
2017Mechanism and Reversal of Acquired Resistance to New Generations of Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsCHIH-HSIN YANGNational Science and Technology Council
2017Deciphering Tumor Immune-Microenvironment in Predciting the Efficacy of Program Cell Death 1 (Pd-1) Checkpoint Bloackade Therapy in Esophageal Squamous Cell CarcinomaCHIH-HUNG HSUNational Science and Technology Council
2017The Correlative Study between Immune Surface Markers with Dynamic Changes and Efficacy of Anti-Cancer Agents for Patients of Metastatic Colorectal Cancers (Crcs) ─ Exploration on Potential Novel Targets of Immunotherapy in CrcsKUN-HUEI YEHNational Science and Technology Council
2017Taiwan Clinical Trial Consortium for Lung CancerCHIH-HSIN YANGNational Science and Technology Council
2016Mechanism and Reversal of Acquired Resistance to New Generations of Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsCHIH-HSIN YANGNational Science and Technology Council
2016Deciphering Tumor Immune-Microenvironment in Predciting the Efficacy of Program Cell Death 1 (Pd-1) Checkpoint Bloackade Therapy in Esophageal Squamous Cell CarcinomaCHIH-HUNG HSUNational Science and Technology Council
2016Taiwan Clinical Trial Consortium for Lung Cancer ViCHIH-HSIN YANGNational Science and Technology Council
2016Taiwan Clinical Trial, Training Center ViCHIH-HSIN YANGNational Science and Technology Council
2015(102CT2018) a Multi-Center Phase II Study of AUY922 in Patients with Stage IV Advanced Non-Small Cell Lung Cancer with Driver Molecular Alterations Other Than Sensitive EGFR Mutation, Who Have Progressed after One Line of Systemic Therapy (III)CHIH-HSIN YANGNational Science and Technology Council
2015Developing Novel Pharmacodynamic and Predictive Biomarkers of Molecularly Targeted Agents in Oncology Phase I TrialsCHIA-CHI LINNational Science and Technology Council
2015Mechanism and Reversal of Acquired Resistance to New Generations of Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsCHIH-HSIN YANGNational Science and Technology Council
2015Impact of Chemotherapy on Immune Microenvironment of Esophageal Squamous Cell Carcinoma---Focusing on the Immune Checkpoint RegulationCHIH-HUNG HSUNational Science and Technology Council
2015Taiwan Clinical Trial Consortium for Oncology Phase I Trials (V)CHIA-CHI LINNational Science and Technology Council
2015(Tr6-2)Taiwan Clinical Trial, Training Center (V)CHIH-HSIN YANGNational Science and Technology Council
2015(TR-4) Taiwan Clinical Trial Consortium for Lung Cancer (V)CHIH-HSIN YANGNational Science and Technology Council
2014(102CT2018) a Multi-Center Phase II Study of AUY922 in Patients with Stage IV Advanced Non-Small Cell Lung Cancer with Driver Molecular Alterations Other Than Sensitive EGFR Mutation, Who Have Progressed after One Line of Systemic Therapy (II)CHIH-HSIN YANGNational Science and Technology Council
2014Taiwan Clinical Trial Consortium for Oncology Phase I Trials (IV)CHIA-CHI LINNational Science and Technology Council
2014Autophage in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance of Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2014Developing Novel Pharmacodynamic and Predictive Biomarkers of Molecularly Targeted Agents in Oncology Phase I TrialsCHIA-CHI LINNational Science and Technology Council
2014Targeting Actionable Genetic Alterations as Novel Therapeutics for Esophageal Squamous Cell CarcinomaCHIH-HUNG HSUNational Science and Technology Council
2014(TR6-2) Taiwan Clinical Trial, Training Center (IV)CHIH-HSIN YANGNational Science and Technology Council
2014(TR4) Taiwan Clinical Trial Consortium for Lung Cancer (IV)CHIH-HSIN YANGNational Science and Technology Council
2013(102ct2018) A Multi-Center Phase II Study of AUY922 in Patients with Stage IV Advanced Non-Small Cell Lung Cancer with Driver Molecular Alterations Other Than Sensitive EGFR Mutation, Who Have Progressed after One Line of Systemic Therapy (I)CHIH-HSIN YANGNational Science and Technology Council
2013Developing Novel Pharmacodynamic and Predictive Biomarkers of Molecularly Targeted Agents in Oncology Phase I TrialsCHIA-CHI LINNational Science and Technology Council
2013Autophage in epidermal growth factor receptor tyrosine kinase inhibitor resistance of lung cancer cellsCHIH-HSIN YANGNational Science and Technology Council
2013National Training Center for Clinical Trial and Translational Research (NTC-CTTR) (III)CHIH-HSIN YANGNational Science and Technology Council
2013Clinical Trials's Consortium, Resource Center of Translational Medicine: Oncology (III)CHIA-CHI LINNational Science and Technology Council
2013Resource Center for Translational Medicine---Taiwan Lung Cancer Clinical Trial Consortium (III)CHIH-HSIN YANGNational Science and Technology Council
2013(100cap020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (III)CHIH-HUNG HSUNational Science and Technology Council
2012Autophage in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance of Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2012Roles of the Hedgehog (Hh) Pathway and Smoothened (Smo) Inhibitors for the Development of Novel Targeted Therapy for Gastric Cancers (2) 全文電子檔： [全文下載1]KUN-HUEI YEHNational Science and Technology Council
2012Clinical Trials Consortium, Resource Center of Translational Medicine---Oncology (II)CHIA-CHI LINNational Science and Technology Council
2012National Training Center for Clinical Trail and Translational Research (II)CHIH-HSIN YANGNational Science and Technology Council
2012(100CAP020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (II)CHIH-HUNG HSUNational Science and Technology Council
2012Resource Center for Translational Medicine---Taiwan Clinical Trial Consortium-Lung Cancer (II)CHIH-HSIN YANGNational Science and Technology Council
2011Detection of Gene Mutations in Nonsmall Cell Lung Cancer Cells in Blood Samples or Fine-Needle AspiratesCHIH-HSIN YANGNational Science and Technology Council
2011Development of Novel Targeted Therapy for Gastric Cancer---With Emphasis on Pivotal Roles of the Hedgehog (Hh) Pathway and Smoothened (SMO) InhibitionKUN-HUEI YEHNational Science and Technology Council
2011National Training Center for Clinical Trial and Translational Research (NTC-CTTR) (I)CHIH-HSIN YANGNational Science and Technology Council
2011(100CAP020-2) in vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (I)CHIH-HUNG HSUNational Science and Technology Council
2011(100TR007) Resource Center of Translational Medicine---Taiwan Clinical Trial Consortium---Lung Cancer (I)CHIH-HSIN YANGNational Science and Technology Council
2010Detection of Gene Mutations in Nonsmall Cell Lung Cancer Cells in Blood Samples or Fine-Needle AspiratesCHIH-HSIN YANGNational Science and Technology Council
2010Exploring Molecular Targets for the Treatment of Hepatocellular Carcinoma---An Alternative ApproachCHIH-HUNG HSUNational Science and Technology Council
2010Factors Affecting Biomarker Detection for the Implementation of Personalized Therapy for Hepatocellular Carcinoma (HCC) and Their Optimization (II)CHIH-HUNG HSUNational Science and Technology Council
2009Detection of Gene Mutations in Nonsmall Cell Lung Cancer Cells in Blood Samples or Fine-Needle AspiratesCHIH-HSIN YANGNational Science and Technology Council
2009Exploring Molecular Targets for the Treatment of Hepatocellular Carcinoma---An Alternative ApproachCHIH-HUNG HSUNational Science and Technology Council
2009Pharmacogenomic Study of High-Dose 5-Fu Associated Hyperammonemic Encephalopathy in Cancer PatientsKUN-HUEI YEHNational Science and Technology Council
2009Factors Affecting Biomarker Detection for the Implementation of Personalized Therapy for Hepatocellular Carcinoma (Hcc) and Their Optimization (I)CHIH-HUNG HSUNational Science and Technology Council
2008Resistance to Epidermal Growth Factor Receptor Inhibitors in Nonsmall Cell Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2008Exploring Molecular Targets for the Treatment of Hepatocellular Carcinoma---An Alternative ApproachCHIH-HUNG HSUNational Science and Technology Council
2008Pharmacogenomic Study of High-Dose 5-Fu Associated Hyperammonemic Encephalopathy in Cancer PatientsKUN-HUEI YEHNational Science and Technology Council
2007Resistance to Epidermal Growth Factor Receptor Inhibitors in Nonsmall Cell Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2007PI3K/Akt/mTOR Pathway-Targeting Agents in the Treatment of Hepatocellular Carcinoma---Exploration of the Possible Clinical Applications and the Molecular MechanismsCHIH-HUNG HSUNational Science and Technology Council
2007PI3K/Akt/mTOR Pathway-Targeting Agents in the Treatment of Hepatocellular Carcinoma---Exploration of the Possible Clinical Applications and the Molecular MechanismsCHIH-HUNG HSUNational Science and Technology Council
2007Pharmacogenomic Study of High-Dose 5-Fu Associated Hyperammonemic Encephalopathy in Cancer PatientsKUN-HUEI YEHNational Science and Technology Council
2007Establishment of Clinical Research Center for TCM in the National Taiwan University HospitalCHIH-HSIN YANGMinistry of Health and Welfare
2006Resistance to Epidermal Growth Factor Receptor Inhibitors in Nonsmall Cell Lung Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2006PI3K/Akt/mTOR Pathway-Targeting Agents in the Treatment of Hepatocellular Carcinoma---Exploration of the Possible Clinical Applications and the Molecular MechanismsCHIH-HUNG HSUNational Science and Technology Council
2006Translational Research on Signal Transduction Inhibition of Epidermal Growth Factor Receptor (EGFR) for Enhancing Chemotherapeutic Effects of Advanced Gastric Cancer---In vitro Model and Clinical StudiesKUN-HUEI YEHNational Science and Technology Council
2006Establishment of Clinical Research Center for TCM in the National Taiwan University HospitalCHIH-HSIN YANGMinistry of Health and Welfare
2005The Effect of Hypoxia on Tumor Growth and Drug Resistance in Tumor Bearing Mice---Establishment of an Animal Model (III)CHIH-HSIN YANGNational Science and Technology Council
2005Targeting PI3K/AKT and Related Signaling Pathways in the Treatment of Nasopharyngeal Carcinoma---Further Exploration of the Molecular Mechanisms and Clinical ImplicationsCHIH-HUNG HSUNational Science and Technology Council
2005Analysis on Epidermal Growth Factor Receptor (EGFR) Gene Mutations and Signal Transduction Inhibition for Prediction of Treatment Response of Cetuximab in Advanced/Metastatic Colorectal CancersKUN-HUEI YEHNational Science and Technology Council
2004The Effect of Hypoxia on Tumor Growth and Drug Resistance in Tumor Bearing Mice---Establishment of an Animal Model (II)CHIH-HSIN YANGNational Science and Technology Council
2004Genetic Polymorphism of UGT1A1 (UDP-Glucuronosyl Transferase 1A1) in Taiwanese Cancer Patients and Correlation with the Toxicity of Irinotecan (CPT-11)-Based ChemotherapyKUN-HUEI YEHNational Science and Technology Council
2003The Effect of Hypoxia on Tumor Growth and Drug Resistance in Tumor Bearing Mice---Establishment of an Animal Model (I)CHIH-HSIN YANGNational Science and Technology Council
2003Study on Alterations of Cell Cycle Regulators and Chemotherapy Resistance in Gastric Cancers---With Emphasis on Development of Innovative Chemotherapeutic Strategy (III)KUN-HUEI YEHNational Science and Technology Council
2002Confirmation of Expression of cDNA Microarray Defined Resistance-Associated Genes in Multidrug Resistant Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2002Studies on the Mechanisms of Activation of Hepatitis B Virus (HBV) Replication Induced by Anticancer DrugsCHIH-HUNG HSUNational Science and Technology Council
2002Study on Alterations of Cell Cycle Regulators and Chemotherapy Resistance in Gastric Cancers---With Emphasis on Development of Innovative Chemotherapeutic Strategy (II)KUN-HUEI YEHNational Science and Technology Council
2002臺灣肺癌之基因體研究及臨床應用---著重於女性肺腺癌---分項計畫四：肺癌之診斷標誌及治療---應用基因微陣列分析探討抗藥機制(III)CHIH-HSIN YANGNational Science and Technology Council
2001Identification of Multidrug Resistant Related Genes in Cancer Cells through DNA Microarray-Based TechniquesCHIH-HSIN YANGNational Science and Technology Council
2001Studies on Epstein-Barr Virus (EBV) Reactivation Induced by Anti-Cancer Drugs---Mechanisms and Clinical SignificanceCHIH-HUNG HSUNational Science and Technology Council
2001Study on Alterations of Cell Cycle Regulators and Chemotherapy Resistance in Gastric Cancers---With Emphasis on Development of Innovative Chemotherapeutic Strategy (I)KUN-HUEI YEHNational Science and Technology Council
2000Topotecan Resistance in BCRP/MXR/ABCP Transfected Breast Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
2000Studies on Treatment and Biology of Common Cancers in TaiwanKUN-HUEI YEHMinistry of Health and Welfare
1999Topotecan Uptake and Efflux in Topotecan Resistant Cancer CellsCHIH-HSIN YANGNational Science and Technology Council
1999Studies on Treatment and Biology of Common Cancers in TaiwanCHIH-HSIN YANGMinistry of Health and Welfare
1998Drug Resistance and Apoptosis in Lung AdenocarcinomaCHIH-HSIN YANGNational Science and Technology Council
1998Studies on the Roles of Expression of Mismatch Repair Genes and Microsatellite Instability in Drug Resistance of Gastric Cancer CellsKUN-HUEI YEHNational Science and Technology Council
1997Drug Resistance and Apoptosis in Lung AdenocarcinomaCHIH-HSIN YANGNational Science and Technology Council
1997Genetic Polymorphism of Dihydropyrimidine Dehydrogenase of the Cancer Patients in Taiwan---With Special Emphasis on Its Relationship with 5-Fluorouracil-Related NeurotoxicityKUN-HUEI YEHNational Science and Technology Council
1996Drug Resistance and Apoptosis in Lung AdenocarcinomaCHIH-HSIN YANGNational Science and Technology Council